Guizhou Bailing Group Pharmaceutical Co., Ltd. (SHE:002424)

China flag China · Delayed Price · Currency is CNY
5.18
+0.11 (2.17%)
Mar 10, 2026, 3:04 PM CST
34.20%
Market Cap 6.92B
Revenue (ttm) 3.15B
Net Income (ttm) 2.22M
Shares Out 1.37B
EPS (ttm) 0.00
PE Ratio 3,116.92
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 17,844,759
Average Volume 25,532,344
Open 5.14
Previous Close 5.07
Day's Range 5.08 - 5.28
52-Week Range 3.66 - 6.94
Beta 0.53
RSI 63.22
Earnings Date Apr 24, 2026

About SHE:002424

Guizhou Bailing Group Pharmaceutical Co., Ltd., together with its subsidiaries, researches, develops, produces, and sells medicines in China. It operates through four segments: Industrial, Commerce, Medical institutions, and Others The company offers medicines in various forms, including tablets, capsules, granules, syrups, powders, pills, dews, pastes, sprays, and oral liquids, as well as wines and honey. Its products are used for cardiovascular, cough, cold, gynecological, and pediatric areas. The company was incorporated in 1999 and is headq... [Read more]

Sector Healthcare
Founded 1999
Employees 6,586
Stock Exchange Shenzhen Stock Exchange
Ticker Symbol 002424
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.